- Bagnaia eyeing summit on home ground in 100th MotoGP
- 'Something was wrong', defendant in French mass rape tells court
- Hezbollah chief admits 'unprecedented' blow in device blasts
- Sales of US existing homes slip slightly in August
- Fear, panic haunt Lebanese after devices explode
- Labuschagne sparks Australia fightback in England ODI opener
- S.Africa's HIV research power couple says fight goes on
- Why is Israel focusing on border with Lebanon?
- Mpox vaccines administered in Rwanda, first in Africa
- US Fed rate cut is 'very positive sign' for economy: Yellen
- Unknown Mozart string trio discovered in Germany
- 'Are we five-year-olds?' F1 drivers won't mind their language
- Brazil judge orders X to reimpose block or face hefty fine
- Munich to rename stadium street after Beckenbauer
- Champions Italy to face Argentina in Davis Cup Final 8
- The winding, fitful path to weight loss drug Ozempic
- Italians defeat American Magic to reach Louis Vuitton Cup final
- Norris has 'nothing to lose' as he hunts Verstappen in Singapore
- Kyiv 'outraged' at Swiss showing of Russian war film
- French city renames Abbe Pierre square after abuse claims
- Footballer charged after huge cannabis seizure at UK airport
- Vatican recognises Medjugorje shrine, but not Virgin's messages
- Israel bombs Hezbollah strongholds in Lebanon after wave of deadly blasts
- Bank of England freezes rate after jumbo US cut
- Playing Nadal is 'kind of a nightmare', says Alcaraz
- Portugal tackles last of deadly northern forest fires
- Ton-up Ashwin lifts India to 339-6 against Bangladesh
- Departing NATO chief warns US against 'isolationism'
- Coming winter 'sternest test yet' for Ukraine energy grid
- Evacuations as tail of Storm Boris floods northeast Italy
- Lebanon's Hezbollah reeling after second wave of deadly blasts
- Taiwan recognises same-sex marriages between Chinese, Taiwanese
- Stock markets rally after jumbo US rate cut
- Gabon's ousted leader Bongo says renouncing politics for good
- Lebanon device blasts: what we know about deadly attacks
- Equity markets rally after jumbo US rate cut
- Late Harrods owner Al-Fayed accused of rape: BBC
- Hong Kong man sentenced 14 months for wearing 'seditious' T-shirt
- Lebanon's Hezbollah in disarray after second wave of deadly blasts
- Equity markets, yen rally after jumbo US rate cut
- Meta and Spotify blast EU decisions on AI
- Hasan takes three as Bangladesh rattle India in first Test
- Two killed during police operation in New Caledonia
- Flood-hit region leaders to meet in Poland to discuss EU aid
- Sri Lanka to vote in first poll since economic collapse
- Hong Kong probe finds Cathay Airbus defect could cause 'extensive' damage
- AI development cannot be left to market whim, UN experts warn
- All Blacks primed for 'hell' of a Wallabies clash
- Japan firm says no longer makes radio reportedly used in Lebanon blasts
- Zoom fatigue? Try some nature in your background: study
Unilever won't up £50 bn offer for GSK-Pfizer unit
Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.
British group GSK at the weekend said it had received three unsolicited offers from Unilever for GSK Consumer Healthcare -- all of which were rejected for being too low.
US company Pfizer owns a minority stake in the unit.
"Unilever is committed to maintaining strict financial discipline to ensure that acquisitions create value for our shareholders," it said in a statement Wednesday, adding that it would not raise the offer above £50 billion ($68 billion).
British company Unilever on Monday said its "future strategic direction lies in materially expanding its presence in health, beauty and hygiene".
GSK Consumer Healthcare's leading products include Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu.
Unilever's major offerings include Magnum ice cream, Cif surface cleaner and Dove soap.
"Unilever... reiterates its commitment to continuing to improve the performance of its existing portfolio through its ongoing focus on operational excellence, its upcoming reorganisation and by rotating the portfolio to higher growth categories," it added Wednesday.
Unilever recently agreed to sell its global tea business, including brands Lipton and PG Tips, for 4.5 billion euros to private equity group CVC Capital Partners.
Ahead of Unilever appearing to have closed the door on the healthcare unit, analysts said private equity groups would likely be interested in bidding for GSK Consumer Healthcare.
Unilever's last bid in December comprised £41.7 billion in cash and £8.3 billion in Unilever shares.
The offers came as GSK was looking to spin off the consumer health division to concentrate on its main pharmaceutical arm.
GSK is led by Emma Walmsley, one of only eight women chief executives running companies on London's benchmark FTSE 100 index.
Walmsley, who headed the GSK consumer unit before its merger with Pfizer and her promotion to GlaxoSmithKline CEO, has faced severe shareholder pressure over her company's delays in producing Covid jabs and treatments.
The consumer healthcare business meanwhile had annual sales of £9.6 billion last year.
GSK owns a majority 68 percent of the unit with Pfizer the remainder.
P.Anderson--BTB